Bailey JohnsonIndiana University School of Medicine, Indianapolis, INJane AmbroIndiana University Health, Indianapolis, INSandra K. AlthouseIndiana University Simon Comprehensive Cancer Center, Indianapolis, INTarah Jean BallingerIndiana University Simon Comprehensive Cancer Center, Indianapolis, IN...
Courtney R (2015) The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General, 2014Us Department of Health and Human Services Atlanta, GA: PB - Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease ...
This chapter reviews the clinical, macroscopic, and microscopic features, as well as the differential diagnosis of the most common breast lesions seen in a routine surgical pathology practice. It begins with non-neoplastic breast lesions including those associated with fibrocystic change, metaplasias, ...
The use of immune-checkpoint blockade (ICI) in clinical oncology has revolutionized patient care and improved survival outcomes in many patients with malignancies1. This therapeutic strategy has significantly expanded in the setting of advanced and early-stage breast cancer (BC), but much more work ...
Susan G. Komen Tissue Bank at the Indiana University Simon Cancer Center, Indianapolis, IN, USA Anna Maria V. Storniolo Department Internal Medicine, Division of Medical Oncology, College of Medicine, University of Kentucky, Lexington, KY, USA ...
[3]3Department of Radiation Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine , Indianapolis, IN, United States [4]4Department of Medical Laboratory, School of Laboratory Medicine and Biotechnology, Southern Medical University , Guangzhou, China ...
Libraries were prepared using the KAPA Biosystems NGS kit (Roche Sequencing and Life Science, Indianapolis, IN) and captured using the IDT xGen Exome v1 panel (Integrated DNA Technologies, Inc., Coralville, IA) using the manufacturer-recommended procedure. Sequence data [77] were generated as ...
The Combination of Sunitinib Plus Paclitaxel Demonstrates Promising Activity in the First-Line Treatment of Advanced Breast Cancer Preliminary Results from a Phase I Trial During a poster session, Mark Kozloff, MD, University of Chicago Medical Center, Chicago, IL and Ingalis Hospital, Harvey, IL,...
Indiana University School of Public Health, Bloomington, IN, USA Betsey Zenk Nuseibeh Indiana University School of Medicine, Indianapolis, IN, USA Michelle S. Hoy, Janet E. Panoch, Madison E. Schwarz & Shelley A. Johns Center for Health Services Research, Regenstrief Institute, Indianapolis, IN...
George W. Sledge Jr., MD, Indiana University School of Medicine, Indianapolis, IN, USA Daniel A. Vorobiof, MD, (Sandton Oncology Centre, Johannesburg, South Africa Toru Watanabe, MD, Hamamatsu Oncology Center, Hamamatsu, Japan